DAMORA THERAPEUTICS, INC.

DMRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
3 May 8, 2026 3
8-K May 4, 2026 8-K
ARS May 1, 2026 ARS
DEF 14A Apr 29, 2026 DEF 14A
DEFA14A Apr 29, 2026 DEFA14A
SCHEDULE 13G/A Apr 23, 2026
SCHEDULE 13G/A Apr 23, 2026
8-K Apr 20, 2026 8-K
4 Apr 1, 2026 4
3 Apr 1, 2026 3
4 Mar 25, 2026 4
4 Mar 25, 2026 4
4 Mar 25, 2026 4
4 Mar 25, 2026 4
4 Mar 25, 2026 4
4 Mar 25, 2026 4
3 Mar 25, 2026 3
3 Mar 25, 2026 3
8-K Mar 23, 2026 8-K
S-8 Mar 20, 2026 S-8
10-K Mar 19, 2026 10-K
8-K Mar 10, 2026 8-K
SCHEDULE 13G/A Mar 6, 2026
SCHEDULE 13G Feb 17, 2026
SCHEDULE 13G Feb 17, 2026
← Newer Page 2 of 15 · 351 filings Older →